Description: Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.
Home Page: www.khiron.ca
2300-550 Burrard Street
Vancouver,
BC
V6C 2B5
Canada
Phone:
705 527 3564
Officers
| Name | Title |
|---|---|
| Mr. Alvaro Francisco Torres | Co-Founder, CEO & Director |
| Mr. Vicente Fox | Strategic Advisor & Director |
| Mr. Andres Galofre | Co-Founder & VP of Bus. Devel.s |
| Mr. Joel Friedman | Chief Financial Officer |
| Mr. Manuel Buendia | VP of Operations |
| Mr. Matt Murphy | VP of Compliance |
| Ms. Livia M. Maduri | Gen. Counsel & Corp. Sec. |
| Jon Packer | VP of Communications |
| Mr. Luis Chavez | Country Mang. of Mexico |
| Mr. Marco Algorta | Country Mang. of Uruguay |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |